How has been the historical performance of Godavari Bioref.?
Godavari Bioref. has experienced a decline in financial performance over the past three years, with net sales decreasing from 2,014.69 Cr in March 2023 to 1,870.25 Cr in March 2025, and a negative profit after tax of -23.41 Cr in the latest fiscal year. Key metrics such as operating profit and earnings per share have also significantly worsened during this period.
Answer:The historical performance of Godavari Bioref. shows a decline in key financial metrics over the past three years, particularly in profitability.Breakdown:
In the fiscal year ending March 2025, Godavari Bioref. reported net sales of 1,870.25 Cr, an increase from 1,686.67 Cr in March 2024 but a decrease from 2,014.69 Cr in March 2023. The total operating income mirrored this trend, with figures of 1,870.25 Cr for March 2025, 1,686.67 Cr for March 2024, and 2,014.69 Cr for March 2023. The total expenditure, excluding depreciation, rose to 1,766.60 Cr in March 2025 from 1,553.13 Cr in March 2024, while operating profit (PBDIT) decreased to 120.31 Cr in March 2025 from 147.94 Cr in March 2024 and 154.62 Cr in March 2023. Consequently, profit before tax turned negative at -1.54 Cr in March 2025, down from 12.45 Cr in March 2024 and 31.75 Cr in March 2023. This decline continued with profit after tax, which fell to -23.41 Cr in March 2025 from 12.30 Cr in March 2024 and 19.64 Cr in March 2023. The earnings per share also reflected this downturn, dropping to -4.57 in March 2025 from 2.93 in March 2024 and 4.68 in March 2023. Overall, the company faced significant challenges in maintaining profitability, culminating in a negative net profit for the latest fiscal year.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
